NON ALCOHOLIC FATTY LIVER DISEASE: A BRIEF OVERVIEWAbstract
The occurrence of non-alcoholic fatty liver disease (NAFLD) is around 20-30% in the general population. NAFLD is usually asymptomatic, although a minority of patients may present with evidence of progressive liver injury with complications of cirrhosis, liver failure, and hepatocellular carcinoma. In spite of being common and potentially serious, relatively little is known about the natural history or prognostic significance of NAFLD. The management focuses upon modifying metabolic risk factors. Insulin-sensitizing and hepatoprotective drugs have been subjected to study trials, but up till now, no agent has conclusively been established to prevent disease progression.
J.A. Ansari*, K. Shakil and A. Rashid
Department of Pharmacology, MESCO College of Pharmacy , Mustaidpura, Hyderabad-500006, Andhra Pradesh, India
04 June, 2012
11 July, 2012
10 September, 2012
01 October, 2012